Literature DB >> 19637923

Impact of metal coordination on cytotoxicity of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine) and novel insights into terminal dimethylation.

Christian R Kowol1, Robert Trondl, Petra Heffeter, Vladimir B Arion, Michael A Jakupec, Alexander Roller, Mathea Sophia Galanski, Walter Berger, Bernhard K Keppler.   

Abstract

The first metal complexes of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (Triapine) were synthesized. Triapine was prepared by a novel three-step procedure in 64% overall yield. In addition, a series of related ligands, namely, 2-formylpyridine thiosemicarbazone, 2-acetylpyridine thiosemicarbazone, 2-pyridineformamide thiosemicarbazone, and their N(4)-dimethylated derivatives (including the N(4)-dimethylated analogue of Triapine) were prepared, along with their corresponding gallium(III) and iron(III) complexes with the general formula [M(L)(2)](+), where HL is the respective thiosemicarbazone. The compounds were characterized by elemental analysis, (1)H and (13)C NMR, IR and UV-vis spectroscopies, mass spectrometry, and cyclic voltammetry. In addition, Triapine and its iron(III) and gallium(III) complexes were studied by X-ray crystallography. All ligands and complexes were tested for their in vitro antiproliferative activity in two human cancer cell lines (41M and SK-BR-3), and structure-activity relationships were established. In general, the coordination to gallium(III) increased the cytotoxicity while the iron(III) complexes show reduced cytotoxic activity compared to the metal-free thiosemicarbazones. Selected compounds were investigated for the capacity of inhibiting ribonucleotide reductase by incorporation of (3)H-cytidine into DNA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19637923     DOI: 10.1021/jm900528d

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  32 in total

1.  Biological assays and noncovalent interactions of pyridine-2-carbaldehyde thiosemicarbazonecopper(II) drugs with [poly(dA-dT)](2), [poly(dG-dC)] (2), and calf thymus DNA.

Authors:  Rebeca Ruiz; Begoña García; Javier Garcia-Tojal; Natalia Busto; Saturnino Ibeas; José M Leal; Célia Martins; Jorge Gaspar; Joaquín Borrás; Rubén Gil-García; Marta González-Alvarez
Journal:  J Biol Inorg Chem       Date:  2010-01-20       Impact factor: 3.358

2.  Multifunctional thiosemicarbazones and deconstructed analogues as a strategy to study the involvement of metal chelation, Sigma-2 (σ2) receptor and P-gp protein in the cytotoxic action: In vitro and in vivo activity in pancreatic tumors.

Authors:  Maria Laura Pati; Mauro Niso; Dirk Spitzer; Francesco Berardi; Marialessandra Contino; Chiara Riganti; William G Hawkins; Carmen Abate
Journal:  Eur J Med Chem       Date:  2017-12-08       Impact factor: 6.514

3.  Mechanisms underlying reductant-induced reactive oxygen species formation by anticancer copper(II) compounds.

Authors:  Christian R Kowol; Petra Heffeter; Walter Miklos; Lars Gille; Robert Trondl; Loredana Cappellacci; Walter Berger; Bernhard K Keppler
Journal:  J Biol Inorg Chem       Date:  2011-12-22       Impact factor: 3.358

4.  68Ga-labeled inhibitors of prostate-specific membrane antigen (PSMA) for imaging prostate cancer.

Authors:  Sangeeta Ray Banerjee; Mrudula Pullambhatla; Youngjoo Byun; Sridhar Nimmagadda; Gilbert Green; James J Fox; Andrew Horti; Ronnie C Mease; Martin G Pomper
Journal:  J Med Chem       Date:  2010-07-22       Impact factor: 7.446

5.  Distinct mechanisms of cell-kill by triapine and its terminally dimethylated derivative Dp44mT due to a loss or gain of activity of their copper(II) complexes.

Authors:  Kimiko Ishiguro; Z Ping Lin; Philip G Penketh; Krishnamurthy Shyam; Rui Zhu; Raymond P Baumann; Yong-Lian Zhu; Alan C Sartorelli; Thomas J Rutherford; Elena S Ratner
Journal:  Biochem Pharmacol       Date:  2014-08-15       Impact factor: 5.858

6.  Interaction of Triapine and related thiosemicarbazones with iron(III)/(II) and gallium(III): a comparative solution equilibrium study.

Authors:  Éva A Enyedy; Michael F Primik; Christian R Kowol; Vladimir B Arion; Tamás Kiss; Bernhard K Keppler
Journal:  Dalton Trans       Date:  2011-04-27       Impact factor: 4.390

7.  Activity and electrochemical properties: iron complexes of the anticancer drug triapine and its analogs.

Authors:  Daniel Sun; Juno Van Valkenburgh; Sheba Plamthottam; Jeffrey Valenzuela; Bastian Ruehle; Dalton Steele; Soumya Poddar; Maxim Marshalik; Selena Hernandez; Caius Gabriel Radu; Jeffrey I Zink
Journal:  J Biol Inorg Chem       Date:  2019-06-27       Impact factor: 3.358

8.  Assessment of the in vitro toxicity of calixarenes and a metal-seamed calixarene: a chemical pathway for clinical application.

Authors:  Arnab Dawn; Xue Yao; Ying Yu; Jianxiong Jiang; Harshita Kumari
Journal:  Supramol Chem       Date:  2019-05-13       Impact factor: 1.688

Review 9.  Iron-targeting antitumor activity of gallium compounds and novel insights into triapine(®)-metal complexes.

Authors:  Christopher R Chitambar; William E Antholine
Journal:  Antioxid Redox Signal       Date:  2012-10-03       Impact factor: 8.401

10.  Mechanistic studies of semicarbazone triapine targeting human ribonucleotide reductase in vitro and in mammalian cells: tyrosyl radical quenching not involving reactive oxygen species.

Authors:  Yimon Aye; Marcus J C Long; JoAnne Stubbe
Journal:  J Biol Chem       Date:  2012-08-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.